Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells. | J Cancer Res Ther | 2024 | 38687926 | PubTator, text mining | PubMed |
| RSK/GSK3-mediated phosphorylation of FilGAP regulates chemotactic cancer invasion. | PNAS Nexus | 2024 | 38426123 | PubTator, text mining | PubMed |
| Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs. | Pathogens | 2024 | 38392865 | PubTator, text mining | PubMed |
| Exploration of functional relations among differentially co-expressed genes identifies regulators in glioblastoma. | Comput Biol Chem | 2024 | 38335855 | PubTator, text mining | PubMed |
| Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia. | Sci Rep | 2024 | 38233537 | PubTator, text mining | PubMed |
| Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing. | Chem Biol Drug Des | 2024 | 38230791 | PubTator, text mining | PubMed |
| Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN. | NAR Cancer | 2024 | 38213997 | PubTator, text mining | PubMed |
| HSPB8 Facilitates the Oncogenesis and Advancement of Bladder Cancer via Activation of HSP27. | J Cancer | 2024 | 38213722 | PubTator, text mining | PubMed |
| Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications. | Virus Res | 2024 | 38211734 | PubTator, text mining | PubMed |
| Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations. | Int J Mol Sci | 2024 | 38203761 | PubTator, text mining | PubMed |
| Inhibition of phosphatidylinositol 3-kinase catalytic subunit alpha by miR-203a-3p reduces hypertrophic scar formation via phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway. | Burns Trauma | 2024 | 38179473 | PubTator, text mining | PubMed |
| Detailed immune profiling in pediatric Crohn's disease using methylation cytometry. | Epigenetics | 2024 | 38090774 | PubTator, text mining | PubMed |
| HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications. | Mol Biotechnol | 2024 | 37955777 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome pathway-mediated regulation of the Bcl-2 family: effects and therapeutic approaches. | Haematologica | 2024 | 37584295 | PubTator, text mining | PubMed |
| Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer. | Biol Trace Elem Res | 2024 | 37528285 | PubTator, text mining | PubMed |
| Roles of ribosomal RNA in health and disease. | Front RNA Res | 2023 | 42212238 | PubTator, text mining | PubMed |
| OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions. | Front Mol Biosci | 2023 | 38264570 | PubTator, text mining | PubMed |
| Machine learning hypothesis-generation for patient stratification and target discovery in rare disease: our experience with Open Science in ALS. | Front Comput Neurosci | 2023 | 38260713 | PubTator, text mining | PubMed |
| BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation. | Int J Mol Sci | 2023 | 38203624 | PubTator, text mining | PubMed |
| Therapeutic targeting of p90 ribosomal S6 kinase. | Front Cell Dev Biol | 2023 | 38169775 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=6